Cargando…
The prevalence of CT-defined low skeletal muscle mass in patients with metastatic cancer: a cross-sectional multicenter French study (the SCAN study)
BACKGROUND: Cachexia, characterized by involuntary muscle mass loss, negatively impacts survival outcomes, treatment tolerability, and functionality in cancer patients. However, there is a limited appreciation of the true prevalence of low muscle mass due to inconsistent diagnostic methods and limit...
Autores principales: | Raynard, Bruno, Pigneur, Frederic, Di Palma, Mario, Deluche, Elise, Goldwasser, François |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8857123/ https://www.ncbi.nlm.nih.gov/pubmed/34862578 http://dx.doi.org/10.1007/s00520-021-06603-0 |
Ejemplares similares
-
Psoas muscle index is not representative of skeletal muscle index for evaluating cancer sarcopenia
por: Pigneur, Frédéric, et al.
Publicado: (2023) -
Is sarcopenia a missed factor in the management of patients with metastatic breast cancer?
por: Deluche, Elise, et al.
Publicado: (2021) -
Weight and skeletal muscle loss with cabozantinib in metastatic renal cell carcinoma
por: Colomba, Emeline, et al.
Publicado: (2022) -
Association between Nutritional Status and Treatment Response and Survival in Patients Treated with Immunotherapy for Lung Cancer: A Retrospective French Study
por: Gouez, Manon, et al.
Publicado: (2022) -
Guidelines for quality control of PET/CT scans in a multicenter clinical study
por: Hristova, Ivalina, et al.
Publicado: (2017)